New injection shows promise for stubborn nail infections
NCT ID NCT07311759
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new injection combining a steroid and antifungal drug against a standard topical cream for chronic paronychia, a long-lasting nail fold infection. Twenty-one adults with at least two affected fingernails on their dominant hand will receive both treatments on different fingers to see which works better. The goal is to find a more effective way to control this condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Triamcinolone acetonide and fluconazole injection
What this could lead to
If successful, this could offer a more effective treatment option for chronic paronychia, potentially reducing the need for long-term topical creams.
What could go wrong
This is a small trial with only 21 participants, so results may not apply to everyone. The injected treatment may cause pain or side effects, and it's unclear if it will be better than standard creams.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PARONYCHIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cairo University
Cairo, Egypt